Mycophenolate Sodium-induced Hepatotoxicity: First Report
Authors:
- Alexandre LoupyALAlexandre Loupy
- Dany AnglicheauDADany Anglicheau
- Marie-France Mamzer-BruneelMMMarie-France Mamzer-Bruneel
- Frank MartinezFMFrank Martinez
- Eric ThervetETEric Thervet
- Chistophe LegendreCLChistophe Legendre
- Jeanne SerpaggiJSJeanne Serpaggi
- Stanislas PolSPStanislas Pol
- 27 August 2006
- journal article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 82 (4) , 581
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Uncommon Side Effect of MMF in Renal Transplant RecipientsRenal Failure, 2005
- Enteric Coated Mycophenolate Sodium is Therapeutically Equivalent to Mycophenolate Mofetil in de novoRenal Transplant PatientsAmerican Journal of Transplantation, 2004
- Enteric-Coated Mycophenolate Sodium can be Safely Administered in Maintenance Renal Transplant Patients: Results of a 1-Year StudyAmerican Journal of Transplantation, 2004
- Drug-Induced HepatotoxicityNew England Journal of Medicine, 2003
- Natural history of liver fibrosis progression in patients with chronic hepatitis CThe Lancet, 1997
- AZATHIOPRINE HEPATITIS IN KIDNEY TRANSPLANT RECIPIENTSTransplantation, 1996